Scott A. Memmott represents life sciences and healthcare organizations in government and internal corporate investigations; civil, criminal, and administrative enforcement actions by government agencies; and complex civil and criminal litigation. Scott handles a range of fraud, abuse, and compliance matters involving the False Claims Act, the Anti-Kickback Statute, the Stark Law, off-label promotion, government reimbursement, and quality of care for global pharmaceutical and medical device manufacturers; biotechnology companies; contract research organizations; diagnostic testing facilities; laboratory equipment manufacturers; and healthcare providers, suppliers, and payors.
Scott also routinely assists clients with government self-disclosures and assesses, designs, consults on and implements mandatory and voluntary compliance and integrity programs, including negotiating Corporate Integrity Agreements with the US Department of Health and Human Services, Office of Inspector General. In addition, Scott is known for his keen understanding of the life sciences and healthcare industries where he has helped design and create collaborations among academic medical centers, private research institutions, pharmaceutical companies, and patient advocacy groups focused on basic scientific research, translational research, drug discovery, and commercialization of drug therapies.
Before entering private practice, Scott defended claims against the US government as a trial attorney in the civil division at the US Department of Justice in Washington, DC, and prosecuted federal criminal matters as a Special Assistant US Attorney in the Eastern District of Virginia. He conducted federal grand jury investigations, supervised federal law enforcement investigations, and served as lead counsel in jury trials in federal courts throughout the United States.
As part of his active pro bono practice and civic activities in the life sciences, Scott acts as outside General Counsel to the National Brain Tumor Society and its subsidiaries, serves as an honorary member of the organization’s board of directors, and chairs its Programs Committee. He also serves on the external advisory board of Targeted Therapies for Glioblastoma, the Brain Cancer Specialized Programs of Research Excellence (SPORE) at Massachusetts General Hospital funded by grants from the National Institutes of Health through the National Cancer Institute’s Translational Research Program.
Additionally, Scott has served for over a decade as outside General Counsel to the National 9/11 Pentagon Memorial Fund Inc., a nonprofit organization established to raise funds to construct, maintain, and operate the congressionally authorized national memorial to honor those killed in the 2001 terrorist attack on the Pentagon. Pro bono efforts led by Scott have received three local and two national pro bono awards.
Scott has been recognized as a Life Sciences Star in Fraud and Abuse by the Legal Media Group, and he publishes and lectures frequently on government enforcement, fraud and abuse, and corporate compliance issues.
Before joining Morgan Lewis, Scott was the national vice chair of the healthcare group at another international law firm. He spent 14 years on active duty in the US Coast Guard.
University of Virginia School of Law, 1996, J.D.
U.S. Coast Guard Academy, 1987, B.S., With High Honors
District of Columbia
Awards and Affiliations
Listed, Legal Media Group's Life Sciences "Life Sciences Star" – Fraud and Abuse (2012–2015)
Member, American Health Lawyers Association
Member, White Collar Crime Committee, Health Law Section and Litigation Section, American Bar Association
Member, Healthcare Compliance Association
Member, Health Law Section, District of Columbia Bar Association